Citations

Clear

2303 citation(s) found for "Yu, Edward".

Distinct Endocytic Responses of Heteromeric and Homomeric Transforming Growth Factor β Receptors
Arline, Sandra L., Doré, Jules J.E., Leof, Edward B. , Anders, Robert A.

Mayo Clinic

Molecular Biology of the Cell | July 2, 2013 | Volume: 8 | Issue: 11 | Pages: 2133-2143

10.1091/mbc.8.11.2133 | PMID 9362058 Get It

Transforming growth factor β (TGFβ) family ligands initiate a cascade of events capable of modulating cellular growth and differentiation. The receptors responsible for transducing these cellular signals are referred to as the type I and type II TGFβ receptors. Ligand binding to the type II receptor results in the transphosphorylation and activation of the type I receptor. This heteromeric complex then propagates the signal(s) to downstream effectors. There is presently little data concerning the fate of TGFβ receptors after ligand binding, with conflicting reports indicating no change or decreasing cell surface receptor numbers. To address the fate of ligand-activated receptors, we have used our previously characterized chimeric receptors consisting of the ligand binding domain from the granulocyte/macrophage colony-stimulating factor α or β receptor fused to the transmembrane and cytoplasmic domain of the type I or type II TGFβ receptor. This system not only provides the necessary sensitivity and specificity to address these types of questions but also permits the differentiation of endocytic responses to either homomeric or heteromeric intracellular TGFβ receptor oligomerization. Data are presented that show, within minutes of ligand binding, chimeric TGFβ receptors are internalized. However, although all the chimeric receptor combinations show similar internalization rates, receptor down-regulation occurs only after activation of heteromeric TGFβ receptors. These results indicate that effective receptor down-regulation requires cross-talk between the type I and type II TGFβ receptors and that TGFβ receptor heteromers and homomers show distinct trafficking behavior.
Retromer maintains basolateral distribution of the type II TGF-β receptor via the recycling endosome
Yin, Xueqian , Wilkes, Mark C. , Leof, Edward B. , Murphy, Stephen J. , Ji, Yan

Mayo Clinic

Molecular Biology of the Cell | May 30, 2013 | Volume: 24 | Issue: 14 | Pages: 2285-2298

10.1091/mbc.e13-02-0093 | PMID 23720763 Get It

Transforming growth factor β (TGF-β) is critical for the development and maintenance of epithelial structures. Because receptor localization and trafficking affect the cellular and organismal response to TGF-β, the present study was designed to address how such homeostatic control is regulated. To that end, we identify a new role for the mammalian retromer complex in maintaining basolateral plasma membrane expression of the type II TGF-β receptor (TβRII). Retromer and TβRII associate in the presence or absence of TGF-β ligand. After retromer knockdown, although TβRII internalization and trafficking to a Rab5-positive compartment occur as in wild-type cells, receptor recycling is inhibited. This results in TβRII mislocalization from the basolateral to both the basolateral and apical plasma membranes independent of Golgi transit and the Rab11-positive apical recycling endosome. The data support a model in which, after initial basolateral TβRII delivery, steady-state polarized TβRII expression is maintained by retromer/TβRII binding and delivery to the common recycling endosome.
CD40 Mediates Downregulation of CD32B on Specific Memory B Cell Populations in Rheumatoid Arthritis
Zhang, Xiaoyu , Burch, Erin, So, Edward , Hubbard, Fleesie, Matteson, Eric L. , Strome, Scott E. , Cai, Ling

Mayo Clinic

The Journal of Immunology | May 18, 2013 | Volume: 190 | Issue: 12 | Pages: 6015-6022

10.4049/jimmunol.1203366 | PMID 23686494 Get It

Abstract Altered B cell function is important in the pathogenesis of rheumatoid arthritis (RA). In this report, we show that patients with active RA have an increased frequency of CD32B low/neg cells in the CD27+IgD− memory B cell subset and that these changes are associated with phenotypic and functional B cell activation. Studies using PBMCs from healthy donors revealed that downregulation of CD32B on B cells is mediated by CD40–CD40L interactions and is potentiated by IL-4 and inhibited by both IL-10 and IL-21. These findings appear physiologically relevant because CD4 T cell expression of CD40L correlated with the frequency of CD32B low/neg cells in the CD27+IgD− memory B subset in patients with RA. Our data support a model in which high levels of CD40L, present on circulating T cells in patients with RA, causes B cell activation and CD32B downregulation, resulting in secondary protection of memory B cells from CD32B-mediated cell death.
A multicenter evaluation of a new therapeutic plasma exchange procedure
Winters, Jeffrey L. , Burgstaler, Edwin A. , Gottschall, Jerome L. , Balogun, Rasheed A. , Houghton, Jaime, Lee, Wanda J., Snyder, Edward L. , Winters, Jeffrey L

Mayo Clinic

Transfusion | April 15, 2013 | Volume: 53 | Issue: 12 | Pages: 3269-3278

10.1111/trf.12189 | PMID 23581280 Get It

BackgroundThe AMICUS (Fenwal, Inc.) was cleared in the United States for platelet (PLT) and plasma collection in 1996 with subsequent clearances for the collection of other blood products. Although not previously used for therapeutic plasma exchange (TPE), new disposables, software, and hardware were developed to enable TPE on the AMICUS.Study Design and MethodsA multicenter, randomized, nonblinded, crossover paired treatment protocol was performed. Thirty patients with orders for at least two TPE procedures were randomly assigned to the AMICUS or the COBE Spectra (TerumoBCT) for the first treatment. Each patient was crossed over to the other device using the same procedure settings from the first procedure. The primary objective compared efficiency of plasma removal (EPR) with secondary objectives of comparing PLT and hemoglobin (Hb) waste plasma content, coagulation factor and complement activation, fluid balance tracking accuracy, procedure length, and adverse events.ResultsThe EPR for the AMICUS (81.9 ± 7.62%) was superior to that of the COBE Spectra (75.2 ± 6.29%; p = 0.00001). The AMICUS also demonstrated statistically higher fluid balance accuracy (99.84%) compared to that of the COBE Spectra (98.83%; p < 0.0001) and a statistically shorter procedure time (103.9 ± 30.8 vs. 110.5 ± 27.1 min, p < 0.001). No significant differences with regard to PLT and Hb content in the waste plasma, change in patient PLT count, or changes in markers of coagulation and complement cascade activation were seen. Frequency and severity of adverse reactions were similar.ConclusionThe AMICUS separator can effectively perform TPE. The AMICUS demonstrated superior plasma removal efficiency compared to the COBE Spectra with no evidence of significant differences in PLT removal, hemolysis, and coagulation or complement activation.
National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B
Sorrell, Michael F., Belongia, Edward A. , Costa, José , Gareen, Ilana F. , Grem, Jean L. , Kern, Earl R., McHugh, James A. M., Petersen, Gloria M. , Rein, Michael F., Strader, Doris B., Trotter, Hartwell T., Inadomi, John M.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 150 | Issue: 2 | Pages: 104-110

10.7326/0003-4819-150-2-200901200-00100 | PMID 19124811 Get It

Hepatitis C Virus Genotypes in the United States: Epidemiology, Pathogenicity, and Response to Interferon Therapy
Zein, Nizar N., Rakela, Jorge, Krawitt, Edward L., Reddy, K. Rajender, Tominaga, Tomonari, Persing, David H., Group*, Collaborative Study, Rakela, Jorge, Krawitt, Edward L., Reddy, K. Rajender, Tominaga, Tomonari, Persing, David H., Group*, Collaborative Study

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 125 | Issue: 8 | Pages: 634-639

10.7326/0003-4819-125-8-199610150-00002 | PMID 8849147 Get It

Three-Year Follow-up on Effects of Transdermal Estrogen
Lufkin, Edward G., Riggs, Lawrence B., Riggs, Lawrence B.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 125 | Issue: 1 | Pages: 77

10.7326/0003-4819-125-1-199607010-00014 | PMID 8644993 Get It

Parathyroid Hormone Radioimmunoassays in the Differential Diagnosis of Hypercalcemia Due to Primary Hyperparathyroidism or Malignancy
Lufkin, Edward G., KAO, PAI CHIH, HEATH, HUNTER, KAO, PAI CHIH, HEATH, HUNTER

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 106 | Issue: 4 | Pages: 559-560

10.7326/0003-4819-106-4-559 | PMID 3826956 Get It

Peripheral neuropathy incidence in inflammatory bowel disease
Figueroa, Juan J., Loftus, Edward V. , Harmsen, William S. , Dyck, P. James B. , Klein, Christopher J. , Klein, Christopher J , Loftus, Edward V

Mayo Clinic

Neurology | April 10, 2013 | Volume: 80 | Issue: 18 | Pages: 1693-1697

10.1212/wnl.0b013e3182904d16 | PMID 23576624 Get It